Resultado da Busca
Há 20 horas · TuHURA's lead candidate, IFx-2.0, was safe and well tolerated at once weekly dosing for 3 weeks Eighty percent (80%) of ICI naïve patients with advanced MCC who failed to respond to pembrolizumab ...
Há 20 horas · 03/06/2024 15:30, atualizado 03/06/2024 15:30. Uma pesquisa brasileira inédita foi apresentada na tarde desta segunda (3/6) na ASCO, o congresso de oncologia mais importante do mundo. Os cientistas estudaram a eficácia da imunoterapia associada à quimioterapia tradicional como primeira linha no tratamento de câncer de pênis avançado.
Há 20 horas · Os efeitos imediatos de prazer e relaxamento do cigarro reforçam o hábito, tornando difícil a decisão de parar", acrescentou Fuzita. A pressão social, conforme o oncologista clínico, também desempenha um papel importante. "Se você tem amigos ou familiares que fumam, pode ser difícil parar por causa da influência social e dos gatilhos ...
Há 20 horas · By Jeremy Golden, Benzinga NEEDHAM, MA / ACCESSWIRE / June 3, 2024 / Clinical-stage biopharmaceutical company Candel Therapeutics, Inc. (NASDAQ:CADL) reported updated survival data from its ...
4 de jun. de 2024 · Sex/gender-specific medicine investigates the differences between men and women in relation to disease diagnosis and treatment. These differences result from (sex-based) biological and (gender-based) socioeconomic and cultural environments. Sex refers to the biological attributes that distinguish male, female, and/or intersex according to ...
Há 7 horas · The randomized, controlled clinical trial is specifically looking into the safety and efficacy of CAN-2409 plus valacyclovir (prodrug), together with standard of care (SoC) chemoradiation, followed by resection – if possible – in borderline resectable pancreatic ductal adenocarcinoma (PDAC).
Há 7 horas · The randomized, controlled clinical trial is specifically looking into the safety and efficacy of CAN-2409 plus valacyclovir (prodrug), together with standard of care (SoC) chemoradiation, followed by resection – if possible – in borderline resectable pancreatic ductal adenocarcinoma (PDAC).
